Back to search
Shock, Cardiogenic
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Shock, Cardiogenic trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Shock, Cardiogenic trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Cardiac disease complicated by respiratory insufficiency comprises the most frequent indication for cardiac intensive care unit (CICU) admission, with nearly on…
There are two primary goals of this multicenter clinical trial that combines an FDA device trial and a phase II drug trial in the same study cohort. These two g…
The main purpose of this study is to determine whether differences in myocardial reserve predict clinical outcomes for heart failure patients.
The goal of this observational study is to learn whether information collected during routine hospital care, together with blood and urine samples, can help doc…
Brief Summary: The IVASHOCK trial investigates whether ivabradine can achieve at least one-class improvement in SCAI cardiogenic shock classification compared…
The Elevate™ CS Clinical Feasibility Study is designed to evaluate the initial safety, effectiveness, and device performance of the Magenta Elevate™ System in p…
This pilot study investigates whether giving a short course of intravenous corticosteroids (methylprednisolone) alongside standard medical care can help patient…
The goal of this clinical trial is to learn which treatment strategies improve survival in adult patients with acute myocardial infarction complicated by cardio…